Completed NA INTERVENTIONAL 2-arm NCT04443972

Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement

Evaluation of Injectable Beta- Tricalcium Phosphate as an Occlusive Barrier Membrane in Treatment of Grade ii Furcation Involvement (Clinical and Radiographic Study)

Sponsor: Alexandria University

Conditions Furcation Defects

Interventions Hydroxyapatite bone graft PD VitalOs cement® biodegardable collagen membrane

Updated 4 times since 2020 Last updated: Jun 20, 2020 Started: Apr 12, 2018 Primary completion: Jul 10, 2019 Completion: Feb 4, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Furcation Defects and is currently completed. Alexandria University leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jul 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alexandria University
Hams Hamed Abdelrahman

Data source: Alexandria University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt